0001435064 false --09-30 Q1 2023 0001435064 2022-10-01 2022-12-31 0001435064 CETX:CommonShareMember 2022-10-01 2022-12-31 0001435064 CETX:SeriesOnePreferredStockMember 2022-10-01 2022-12-31 0001435064 2023-02-10 0001435064 2022-12-31 0001435064 2022-09-30 0001435064 CETX:SeriesOnePreferredStockMember 2022-12-31 0001435064 CETX:SeriesOnePreferredStockMember 2022-09-30 0001435064 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001435064 us-gaap:SeriesCPreferredStockMember 2022-09-30 0001435064 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2022-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-09-30 0001435064 us-gaap:CommonStockMember 2022-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001435064 us-gaap:RetainedEarningsMember 2022-09-30 0001435064 us-gaap:TreasuryStockMember 2022-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2022-09-30 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2021-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-09-30 0001435064 us-gaap:CommonStockMember 2021-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001435064 us-gaap:RetainedEarningsMember 2021-09-30 0001435064 us-gaap:TreasuryStockMember 2021-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001435064 2021-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2021-09-30 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2022-10-01 2022-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-10-01 2022-12-31 0001435064 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001435064 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001435064 us-gaap:TreasuryStockMember 2022-10-01 2022-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2022-10-01 2022-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001435064 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001435064 us-gaap:TreasuryStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2022-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001435064 us-gaap:CommonStockMember 2022-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001435064 us-gaap:RetainedEarningsMember 2022-12-31 0001435064 us-gaap:TreasuryStockMember 2022-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2022-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001435064 us-gaap:CommonStockMember 2021-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001435064 us-gaap:RetainedEarningsMember 2021-12-31 0001435064 us-gaap:TreasuryStockMember 2021-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001435064 2021-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-12-31 0001435064 CETX:CemtrexXRIncMember 2022-11-20 2022-11-22 0001435064 CETX:CemtrexXRIncMember 2022-11-22 0001435064 CETX:CemtrexAdvancedTechnologiesIncMember 2022-11-20 2022-11-22 0001435064 CETX:CemtrexAdvancedTechnologiesIncMember 2022-11-22 0001435064 us-gaap:SubsequentEventMember 2023-01-25 2023-01-25 0001435064 2022-01-01 2022-09-30 0001435064 2021-01-01 2021-09-30 0001435064 CETX:SmartDeskMember CETX:SafeAgreementMember 2022-11-20 2022-11-22 0001435064 CETX:CemtrexXRIncMember us-gaap:AccountingStandardsUpdate202008Member 2022-11-20 2022-11-22 0001435064 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-12-31 0001435064 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-10-01 2022-12-31 0001435064 us-gaap:WarrantMember 2022-10-01 2022-12-31 0001435064 us-gaap:WarrantMember 2021-10-01 2021-12-31 0001435064 us-gaap:EmployeeStockOptionMember 2022-10-01 2022-12-31 0001435064 us-gaap:EmployeeStockOptionMember 2021-10-01 2021-12-31 0001435064 CETX:SecurityMember 2022-10-01 2022-12-31 0001435064 CETX:IndustrialServicesMember 2022-10-01 2022-12-31 0001435064 us-gaap:CorporateMember 2022-10-01 2022-12-31 0001435064 CETX:SecurityMember 2021-10-01 2021-12-31 0001435064 CETX:IndustrialServicesMember 2021-10-01 2021-12-31 0001435064 us-gaap:CorporateMember 2021-10-01 2021-12-31 0001435064 CETX:SecurityMember 2022-12-31 0001435064 CETX:SecurityMember 2022-09-30 0001435064 CETX:IndustrialServicesMember 2022-12-31 0001435064 CETX:IndustrialServicesMember 2022-09-30 0001435064 us-gaap:CorporateMember 2022-12-31 0001435064 us-gaap:CorporateMember 2022-09-30 0001435064 us-gaap:SegmentDiscontinuedOperationsMember 2022-12-31 0001435064 us-gaap:SegmentDiscontinuedOperationsMember 2022-09-30 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2022-12-31 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2022-12-31 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2022-12-31 0001435064 CETX:MarketableSecuritiesMember 2022-12-31 0001435064 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001435064 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001435064 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2022-09-30 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2022-09-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2022-09-30 0001435064 CETX:MarketableSecuritiesMember 2022-09-30 0001435064 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001435064 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001435064 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001435064 us-gaap:LandMember 2022-12-31 0001435064 us-gaap:LandMember 2022-09-30 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2022-12-31 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2022-09-30 0001435064 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001435064 us-gaap:FurnitureAndFixturesMember 2022-09-30 0001435064 CETX:ComputersAndSoftwareMember 2022-12-31 0001435064 CETX:ComputersAndSoftwareMember 2022-09-30 0001435064 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001435064 us-gaap:MachineryAndEquipmentMember 2022-09-30 0001435064 us-gaap:PropertyPlantAndEquipmentMember 2022-10-01 2022-12-31 0001435064 us-gaap:PropertyPlantAndEquipmentMember 2021-10-01 2021-12-31 0001435064 CETX:MasterpieceVRMember 2022-12-31 0001435064 CETX:MasterpieceVRMember 2022-09-30 0001435064 2020-11-13 0001435064 2022-01-19 0001435064 CETX:AssetPurchaseAgreementMember CETX:DuconTechnologiesIncMember CETX:GriffinFiltersLLCMember srt:ChiefFinancialOfficerMember 2019-08-30 2019-08-31 0001435064 CETX:GriffinFiltersLLCMember 2022-07-30 2022-07-31 0001435064 CETX:GriffinFiltersLLCMember CETX:AssetPurchaseAgreementMember CETX:DuconToCemtrixTechnologyMember 2022-07-31 0001435064 CETX:GriffinFiltersLLCMember CETX:AssetPurchaseAgreementMember CETX:DuconToCemtrixTechnologyMember 2022-07-30 2022-07-31 0001435064 CETX:GriffinFiltersLLCMember CETX:AssetPurchaseAgreementMember CETX:DuconToCemtrixTechnologyMember 2022-12-31 0001435064 CETX:GriffinFiltersLLCMember CETX:AssetPurchaseAgreementMember CETX:DuconTechnologiesIncMember 2022-09-30 0001435064 CETX:GriffinFiltersLLCMember CETX:AssetPurchaseAgreementMember CETX:DuconToCemtrixTechnologyMember 2022-09-30 0001435064 CETX:SettlementAgreementMember srt:ChiefFinancialOfficerMember CETX:SecuredPromissoryNoteMember 2021-02-26 0001435064 CETX:SettlementAgreementMember srt:ChiefFinancialOfficerMember CETX:SecuredPromissoryNoteMember 2021-02-26 2021-02-26 0001435064 us-gaap:TradeAccountsReceivableMember 2022-12-31 0001435064 us-gaap:ServiceMember 2022-12-31 0001435064 CETX:FultonBankMember 2022-12-31 0001435064 CETX:FultonBankMember 2022-10-01 2022-12-31 0001435064 CETX:FultonBankMember 2022-09-30 0001435064 CETX:FultonBankOneMember 2022-12-31 0001435064 CETX:FultonBankOneMember 2022-10-01 2022-12-31 0001435064 CETX:FultonBankOneMember 2022-09-30 0001435064 CETX:FultonBankTwoMember 2022-12-31 0001435064 CETX:FultonBankTwoMember 2022-10-01 2022-12-31 0001435064 CETX:FultonBankTwoMember 2022-09-30 0001435064 CETX:FultonBankThreeMember 2022-12-31 0001435064 CETX:FultonBankThreeMember 2022-10-01 2022-12-31 0001435064 CETX:FultonBankThreeMember 2022-09-30 0001435064 CETX:FultonBankMortgagePayableMember 2022-12-31 0001435064 CETX:FultonBankMortgagePayableMember 2022-10-01 2022-12-31 0001435064 CETX:FultonBankMortgagePayableMember 2022-09-30 0001435064 CETX:NotesPayableMember 2022-12-31 0001435064 CETX:NotesPayableOneMember 2022-10-01 2022-12-31 0001435064 CETX:NotesPayableOneMember 2022-12-31 0001435064 CETX:NotesPayableOneMember 2022-09-30 0001435064 CETX:NotesPayableTwoMember 2022-12-31 0001435064 CETX:NotesPayableTwoMember 2022-10-01 2022-12-31 0001435064 CETX:NotesPayableTwoMember 2022-09-30 0001435064 CETX:TermLoansMember 2022-12-31 0001435064 CETX:PPPLoansMember 2022-12-31 0001435064 CETX:NotesPayableMember 2022-10-01 2022-12-31 0001435064 CETX:NotesPayableMember 2022-09-30 0001435064 CETX:TermLoansMember 2022-10-01 2022-12-31 0001435064 CETX:TermLoansMember 2022-09-30 0001435064 CETX:PPPLoansMember 2022-10-01 2022-12-31 0001435064 CETX:PPPLoansMember 2022-09-30 0001435064 us-gaap:NotesPayableToBanksMember 2022-12-31 0001435064 us-gaap:NotesPayableToBanksMember 2022-10-01 2022-12-31 0001435064 2021-10-01 2022-09-30 0001435064 CETX:IndustrialServicesSegmentMember CETX:ManchesterMember 2022-12-31 0001435064 CETX:IndustrialServicesSegmentMember CETX:YorkMember 2022-12-31 0001435064 CETX:IndustrialServicesSegmentMember CETX:EmigsvilleMember 2022-12-31 0001435064 CETX:IndustrialServicesSegmentMember CETX:EmigsvilleMember 2022-10-01 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:PuneMember 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:PuneMember 2022-10-01 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:HauppaugeMember 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:HauppaugeMember 2022-10-01 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:HampshireMember 2022-12-31 0001435064 CETX:SecuritySegmentMember CETX:HampshireMember 2022-10-01 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CETX:Segment iso4217:INR iso4217:GBP

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the quarterly period ended December 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the transition period from ___________to ____________

 

Commission File Number 001-37464

 

 

CEMTREX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   30-0399914

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

276 Greenpoint Ave, Suite 208, Brooklyn, NY   11222
(Address of principal executive offices)   (Zip Code)

 

631-756-9116

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which registered
Common Stock   CETX   Nasdaq Capital Market
Series 1 Preferred Stock   CETXP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

  Yes   No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

  Yes   No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

  Yes   No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

As of February 10, 2023, the issuer had 824,568 shares of common stock issued and outstanding.

 

 

 

 
 

 

Table of Contents

 

CEMTREX, INC. AND SUBSIDIARIES

 

INDEX

 

    Page
     
PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements  
     
  Condensed Consolidated Balance Sheets as of December 31, 2022 (Unaudited) and September 30, 2022 3
     
  Condensed Consolidated Statements of Operations for the three months ended December 31, 2022 and December 31, 2021 (Unaudited) 4
     
  Condensed Consolidated Statements of Comprehensive Income/(Loss) for the three months ended December 31, 2022 and December 31, 2021 (Unaudited) 5
     
  Condensed Consolidated Statement of Stockholders’ Equity for the three months ended December 31, 2022 (Unaudited) 6
     
  Condensed Consolidated Statement of Stockholders’ Equity for the three months ended December 31, 2021 (Unaudited) 7
     
  Condensed Consolidated Statements of Cash Flow for the three months ended December 31, 2022 and December 31, 2021 (Unaudited) 8
     
  Notes to Unaudited Condensed Consolidated Financial Statements 10
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
     
Item 4. Controls and Procedures 28
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 29
     
Item 1A Risk Factors 29
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
     
Item 6. Exhibits 30
     
SIGNATURES 31

 

2
 

 

Part I. Financial Information

 

Item 1. Financial Statements

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

   (Unaudited)     
   December 31,   September 30, 
   2022   2022 
Assets          
Current assets          
Cash and equivalents  $5,768,610   $9,895,761 
Restricted cash   1,601,723    1,577,915 
Short-term investments   13,721    13,721 
Trade receivables, net   6,936,077    5,399,216 
Trade receivables - related party   383,710    - 
Inventory –net of allowance for inventory obsolescence   8,604,759    8,487,817 
Prepaid expenses and other assets   3,092,618    2,421,644 
Assets of discontinued operations   -    3,971,693 
Total current assets   26,401,218    31,767,767 
           
Property and equipment, net   5,108,267    5,280,442 
Right-of-use assets   2,520,506    2,641,198 
Royalties receivable - related party   665,048    - 
Note receivable - related party   761,585    761,585 
Goodwill   3,906,891    3,906,891 
Other   1,546,101    1,399,745 
Total Assets  $40,909,616   $45,757,628 
           
Liabilities & Stockholders’ Equity (Deficit)          
Current liabilities          
Accounts payable  $2,722,992   $3,050,937 
Accounts payable - related party   19,034    19,133 
Short-term liabilities   17,099,485    16,894,743 
Lease liabilities - short-term   787,561    754,495 
Deposits from customers   489,669    73,146 
Accrued expenses   3,246,129    2,271,188 
Deferred revenue   2,505,618    1,551,088 
Accrued income taxes   -    94,848 
Liabilities of discontinued operations   -    805,219 
Total current liabilities   26,870,488    25,514,797 
Long-term liabilities          
Loans payable to bank   92,010    110,331 
Long-term lease liabilities   1,732,945    1,822,468 
Mortgage payable   2,142,662    2,160,169 
Other long-term liabilities   582,392    807,898 
Paycheck Protection Program Loans   97,120    97,120 
Deferred Revenue - long-term   595,281    607,309 
Total long-term liabilities   5,242,410    5,605,295 
Total liabilities   32,112,898    31,120,092 
           
Commitments and contingencies   -    - 
           
Shareholders’ equity          
Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 3,000,000 shares authorized, 2,183,463 shares issued and 2,119,363 shares outstanding as of December 31, 2022 and 2,079,122 shares issued and 2,015,022 shares outstanding as of September 30, 2022 (liquidation value of $10 per share)   2,183    2,079 
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at December 31, 2022 and September 30, 2022   50    50 
Common stock, $0.001 par value, 50,000,000 shares authorized, 793,727 shares issued and outstanding at December 31, 2022 and 754,711 shares issued and outstanding at September 30, 2022   794    755 
Additional paid-in capital   66,913,540    66,641,696 
Retained earnings (accumulated deficit)   (61,206,231)   (54,929,020)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at December 31, 2022 and September 30, 2022   (148,291)   (148,291)
Accumulated other comprehensive income (loss)   2,601,094    2,377,525 
Total Cemtrex stockholders’ equity   8,163,139    13,944,794 
Non-controlling interest   633,579    692,742 
Total liabilities and shareholders’ equity  $40,909,616   $45,757,628 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

 

   December 31, 2022   December 31, 2021 
   For the three months ended 
   December 31, 2022   December 31, 2021 
         
Revenues  $11,970,242   $9,413,395 
Cost of revenues   6,927,627    6,191,145 
Gross profit   5,042,615    3,222,250 
Operating expenses          
General and administrative   5,455,833    5,447,951 
Research and development   1,538,218    1,072,898 
Total operating expenses   6,994,051    6,520,849 
Operating loss   (1,951,436)   (3,298,599)
Other income/(expense)          
Other income   (17,083)   930,138 
Interest Expense   (1,128,234)   (1,402,404)
Total other income/(expense), net   (1,145,317)   (472,266)
Net loss before income taxes   (3,096,753)   (3,770,865)
Income tax benefit/(expense)   -    - 
Loss from Continuing operations   (3,096,753)   (3,770,865)
Loss from discontinued operations, net of tax   (3,239,621)   (758,958)
Net loss   (6,336,374)   (4,529,823)
Less loss in noncontrolling interest   (59,163)   (51,872)
Net loss attributable to Cemtrex, Inc. shareholders  $(6,277,211)  $(4,477,951)
Loss Per Share-Basic & Diluted          
Continuing Operations  $(3.99)  $(5.64)
Discontinued Operations  $(4.25)  $(1.15)
Weighted Average Number of Shares-Basic & Diluted   761,571    659,919 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4
 

 

Condensed Consolidated Statements Comprehensive Income/(Loss)

(Unaudited)

 

   December 31, 2022   December 31, 2021 
   For the three months ended 
   December 31, 2022   December 31, 2021 
Other comprehensive income/(loss)          
Net loss  $(6,336,374)  $(4,529,823)
Foreign currency translation (loss)/income   223,569    59,492 
Comprehensive loss   (6,112,805)   (4,470,331)
Less comprehensive loss attributable to noncontrolling interest   (59,163)   (51,872)
Comprehensive loss attributable to Cemtrex, Inc. shareholders  $(6,053,642)  $(4,418,459)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

 

                                                 
                       Treasury             
                       Stock,             
   Preferred Stock Series 1   Preferred Stock Series C  

Common Stock Par

       Retained  

64,100 shares of 

   Accumulated         
   Par Value $0.001   Par Value $0.001   Value $0.001   Additional   Earnings   Series 1   other   Cemtrex   Non- 
   Number of       Number of       Number of       Paid-in   (Accumulated  

Preferred
   Comprehensive   Stockholders’   controlling 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit)   Stock   Income(loss)   Equity   interest 
Balance at September 30, 2022     2,079,122   $2,079          50,000   $50        754,711   $755   $66,641,696   $(54,929,020)  $   (148,291)  $2,377,525   $    13,944,794   $692,742 
Foreign currency translation gain/(loss)             -     -                         -     223,569    223,569      
Share-based compensation             -     -               39,842         -          39,842      
Shares issued to pay notes payable             -     -     39,016    39    232,106         -          232,145      
Dividends paid in Series 1 preferred shares   104,341    104    -     -               (104)        -          -      
Income/(loss) attributable to noncontrolling interest             -     -                         -          -    (59,163)
Net loss             -     -                    (6,277,211)   -          (6,277,211)     
Balance at December 31, 2022   2,183,463   $2,183    50,000   $50    793,727   $794   $66,913,540   $(61,206,231)  $(148,291)  $2,601,094   $8,163,139   $633,579 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6
 

 

Cemtrex, Inc. and Subsidiaries

 

Condensed Consolidated Statement of Stockholders’ Equity (Continued)

(Unaudited)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit)   Stock   Income(loss)   Equity   interest 
                       Treasury             
                       Stock,             
   Preferred Stock Series 1   Preferred Stock Series C   Common Stock Par       Retained   64,100 shares of   Accumulated         
   Par Value $0.001   Par Value $0.001   Value $0.001   Additional   Earnings   Series 1   other   Cemtrex   Non- 
   Number of       Number of       Number of       Paid-in   (Accumulated   Preferred   Comprehensive   Stockholders’   controlling 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit)   Stock   Income(loss)   Equity   interest 
Balance at September 30, 2021    1,885,151   $1,885          50,000   $50        593,777   $594   $61,748,022   $(41,908,062)  $(148,291)  $2,896,452   $  22,590,650   $964,026 
Foreign currency translation gain/(loss)             -     -                         -     59,492    59,492      
Share-based compensation             -     -               45,371         -          45,371      
Shares issued to pay notes payable             -     -     82,600    83    3,287,988         -          3,288,071      
Dividends paid in Series 1 preferred shares   94,602    95    -     -               (95)        -          -      
Income/(loss) attributable to noncontrolling interest             -     -                         -          -    (51,872)
Net loss             -     -                    (4,477,951)   -          (4,477,951)     
Balance at December 31, 2021   1,979,753   $1,980    50,000   $50    676,377   $677   $65,081,286   $(46,386,013)  $(148,291)  $2,955,944   $21,505,633   $912,154 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   2022   2021 
   For the three months ended 
  

December 31,

 
   2022   2021 
Cash Flows from Operating Activities          
           
Net loss  $(6,336,374)  $(4,529,823)
           
Adjustments to reconcile net income/(loss) to net cash used by operating activities          
Depreciation and amortization   530,830    247,704 
(Gain)/loss on disposal of property and equipment   (3,547)   27,170 
Noncash lease expense   197,198    196,572 
Change in allowance for doubtful accounts   4,510    94,588 
Share-based compensation   39,842    45,371 
Interest expense paid in equity shares   32,145    821,592 
Accrued interest on notes payable   528,100    132,162 
Amortization of original issue discounts on notes payable   441,734    325,000 
Gain on marketable securities   -    21 
Discharge of Paycheck Protection Program Loans   -    (971,500)
           
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:          
Trade receivables   (1,541,371)   2,094,282 
Trade receivables - related party   (383,710)   (5,166)
Inventory   (116,942)   (1,458,595)
Prepaid expenses and other current assets   (670,974)   (144,745)
Other assets   (146,356)   (384)
Other liabilities   (225,506)   (88,266)
Accounts payable   (327,945)   (726,226)
Accounts payable - related party   (99)   - 
Operating lease liabilities   (132,963)   (104,644)
Deposits from customers   416,523    205,855 
Accrued expenses   974,941    (142,307)
Deferred revenue   942,502    (286,261)
Income taxes payable   (94,848)   (124,823)
Net cash used by operating activities - continuing operations   (5,872,310)   (3,633,465)
Net cash provided/(used) by operating activities - discontinued operations   2,501,426    (719,237)
Net cash used by operating activities   (3,370,884)   (4,352,702)
           
Cash Flows from Investing Activities          
Purchase of property and equipment   (571,658)   (301,327)
Proceeds from sale of property and equipment   3,547    9,661 
Net cash used by investing activities - continuing operations   (568,111)   (291,666)
Net cash provided by investing activities - discontinued operations   207,329    - 
Net cash provided/(used) by investing activities   (360,782)   (291,666)
           
Cash Flows from Financing Activities          
Payments on notes payable   (294,370)   (326,763)
Payments on bank loans   (306,550)   (305,990)
Net cash used by financing activities   (600,920)   (632,753)
           
Effect of currency translation   229,243    63,228 
Net decrease in cash, cash equivalents, and restricted cash   (4,332,586)   (5,277,121)
Cash, cash equivalents, and restricted cash at beginning of period   11,473,676    17,186,323 
Cash, cash equivalents, and restricted cash at end of period  $7,370,333   $11,972,430 
           
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash          
Cash and equivalents  $5,768,610   $10,338,978 
Restricted cash   1,601,723    1,633,452 
Total cash, cash equivalents, and restricted cash  $7,370,333   $11,972,430 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

8
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)

 

Supplemental Disclosure of Cash Flow Information:        
Cash paid during the period for interest  $126,255   $126,715 
           
Cash paid during the period for income taxes  $94,848   $124,823 
           
Supplemental Schedule of Non-Cash Investing and Financing Activities          
Shares issued to pay notes payable  $232,145   $3,288,071 
Investment in right of use asset  $76,506   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

9
 

 

Cemtrex Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

 

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. The Company currently operates in two areas: industrial services, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company now has three business segments, consisting of (i) Security (ii) Industrial Services and (iii) Cemtrex Corporate.

 

Security

 

Cemtrex’s Security segment operates under the Vicon Industries brand. Vicon Industries, Inc. (“Vicon”), a majority owned subsidiary, provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. We are a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

 

Cemtrex Corporate

 

Cemtrex’s Corporate segment is the holding company of our other two segments.

 

Sale of former Cemtrex Brands

 

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, which include the brand SmartDesk, and Cemtrex XR, Inc., which include the brands Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil.

 

On November 22, 2022, the Company completed the above disposition for the following consideration.

 

Cemtrex XR, Inc.

 

$895,000 comprised of:

 

$75,000 in cash payable at Closing; and
5% royalty of all revenues on the Business to be paid 90 days after the end of each calendar year for the next three years; and should the total sum of royalties due be less than $820,000 at the end of the three-year period, Purchaser shall be obligated to pay the difference between $820,000 and the royalties paid.

 

10
 

 

Cemtrex Advanced Technologies, Inc.

 

$10,000 in cash payable at Closing; and
5% royalty of all revenues on the Business to be paid 90 days after the end of each calendar year for the next 5 years; and
$1,600,000 in SAFE (common equity) at any subsequent fundraising or exit above $5M with a $10M cap.

 

The Company’s Board of Directors, excluding Saagar Govil who abstained from all voting on these agreements, approved these actions and agreements.

 

Reverse Stock Split

 

On January 25, 2023, the company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

 

Extension of cure period

 

On January 26, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that, it had been granted an additional 180 days or until July 24, 2023, to regain compliance with the Minimum Bid Price Requirement on its Series 1 Preferred stock.

 

Listing Rule Compliance

 

On February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company’s common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has been cancelled.

 

Going Concern Considerations

 

The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued.

 

This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued.

 

The Company has incurred substantial losses of $13,020,958 and $7,807,995 for fiscal years 2022 and 2021, respectively, and has losses on continuing operations for the first quarter of fiscal year 2023 of $3,096,753 and has debt obligations over the next year of $17,099,485 and working capital deficit of $469,270, that raise substantial doubt with respect to the Company’s ability to continue as a going concern.

 

11
 

 

While our working capital deficit and current debt indicate a substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. Additionally, the Company has sold unprofitable brands, reducing the cash required to maintain those brands, reevaluated our pricing model on our Vicon brand to improve margins on those products, and has effected a 35:1 reverse stock split on our common stock to remain trading on the Nasdaq Capital Markets, and improve our ability to potentially raise capital through equity offerings that we may use to satisfy debt. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans are sufficient to meet the capital demands of our current operations for at least the next twelve months, the is no guarantee that we will succeed. Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. We currently do not have adequate cash to meet our short or long-term needs. The condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

 

NOTE 2 – INTERIM STATEMENT PRESENTATION

 

Basis of Presentation and Use of Estimates

 

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the year ended September 30, 2022, of Cemtrex Inc.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates its estimates and assumptions on an ongoing basis.

 

The condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, Cemtrex Technologies Pvt. Ltd., Advanced Industrial Services, Inc., and the Company’s majority owned subsidiary Vicon Industries, Inc. and its subsidiary, Vicon Industries Ltd. All inter-company balances and transactions have been eliminated in consolidation.

 

Accounting Pronouncements

 

Significant Accounting Policies

 

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2022, includes a summary of the significant accounting policies used in the preparation of the consolidated financial statements.

 

12
 

 

Recently Issued Accounting Standards

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU No. 2021-08”). ASU No. 2021-08 will require companies to apply the definition of a performance obligation under ASC Topic 606 to recognize and measure contract assets and contract liabilities (i.e., deferred revenue) relating to contracts with customers that are acquired in a business combination. Under current U.S. GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 will result in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements.

 

On June 30, 2022, the FASB issued ASU 2022-03 Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”), which (1) clarifies the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and (2) requires specific disclosures related to such an equity security. Under current guidance, stakeholders have observed diversity in practice related to whether contractual sale restrictions should be considered in the measurement of the fair value of equity securities that are subject to such restrictions. On the basis of interpretations of existing guidance and the current illustrative example in ASC 820-10-55-52 of a restriction on the sale of an equity instrument, some entities use a discount for contractual sale restrictions when measuring fair value, while others view the application of such a discount to be inconsistent with the principles of ASC 820. To reduce the diversity in practice and increase the comparability of reported financial information, ASU 2022-03 clarifies this guidance and amends the illustrative example. ASU No. 2022-03 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements.

 

The Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.

 

 
 

 

NOTE 3 – DISCONTINUED OPERATIONS

 

Due to the on-going losses and risk associated with the SmartDesk business the Company has valued the royalty and SAFE agreement associated with the SmartDesk sale at $0 and considers such consideration to be a gain contingency.

 

Based on sales projections for Cemtrex XR, Inc., the Company does not believe that it will exceed the sales levels required to exceed the $820,000 royalties due and has not accounted for any additional royalties at this time. In accordance with ASC 310 – Receivables, the Company has discounted the royalties due and has recognized $660,621 of royalties due and will amortize the remaining amount over the period the royalties are due.

 

The following table summarizes the loss on the sale:

 

      
Purchase Price  $745,621 
Less cash and cash equivalents transferred   (699,423)
Less Liabilities assumed   (10,924)
Net purchase price  $35,274 
      
Assets Sold     
Accounts receivable, net  $625,638 
Inventory, net   980,730 
Prepaid expenses and other assets   502,577 
Property and equipment, net   837,808 
Goodwill   598,392 
Total Assets Sold   3,545,145 
Liabilities Transferred     
Accounts payable   370,774 
Short-term liabilities   364,775 
Long-term liabilities   318,981 
Total Liabilities Transferred   1,054,530 
Net assets sold  $2,490,615 
      
Pretax loss on sale of Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc.Companies  $(2,455,341)

 

14
 

 

Assets and liabilities included within discontinued operations on the Company’s Condensed Consolidated Balance Sheets at December 31, 2022 and September 30, 2022 are as follows;

 

   December 31,   September 30, 
   2022   2022 
Assets          
Current assets          
Cash and equivalents  $       -   $714,420 
Trade receivables, net   -    561,470 
Inventory –net of allowance for inventory obsolescence   -    1,043,865 
Prepaid expenses and other assets   -    153,461 
Total current assets   -    2,473,216 
           
Property and equipment, net   -    825,850 
Other   -    672,627 
Total Assets  $-   $3,971,693 
           
Liabilities          
Current liabilities          
Accounts payable  $-   $205,622 
Short-term liabilities   -    464,429 
Deposits from customers   -    125,032 
Accrued expenses   -    10,136 
Total current liabilities   -    805,219 
           
Long-term liabilities          
Deferred revenue        6,273 
Total long-term liabilities   -    6,273 
Total liabilities  $-   $811,492 

 

Loss from discontinued operations, net of tax and the loss on sale of discontinued operations, net of tax, of Cemtrex Advanced Technologies, Inc. and Cemtrex XR, Inc., sold during the first quarter of fiscal year 2023, which are presented in total as discontinued operations, net of tax in the Company’s Condensed Consolidated Statements of Operations for the three-month periods ended December 31, 2022 and 2021, are as follows:

 

   2022   2021 
   Three months ended December 31, 
   2022   2021 
         
Total net sales  $649,061   $1,259,904 
Cost of sales   228,086    612,150 
Operating, selling, general and administrative expenses   1,295,572    1,402,961 
Other expenses   3,195    3,034 
Income (loss) from discontinued operations   (877,792)   (758,241)
Amortization of discounted royalties   4,427    - 
Loss on sale of discontinued operations   (2,455,341)   - 
Income tax provision   -    - 
Discontinued operations, net of tax   (3,328,706)   (758,241)

 

During the quarter ended December 31, 2022, Vicon completed the closure of its discontinued operating entity Vicon Systems, Ltd. located in Israel. The Company received funds of $96,095, which at the time of operational closure were not guaranteed to be retrievable. The company paid $7,010 in consulting fees for assistance in retrieving these funds. The net amount of $89,085 is recognized on the Company’s Condensed Consolidated Income Statement as part of the Loss on Discontinued Operations.

 

15
 

 

NOTE 4 – LOSS PER COMMON SHARE

 

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. For the three months ended December 31, 2022, and 2021, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

   2022   2021 
   For the three months ended 
   December 31, 
   2022   2021 
         
Warrants to purchase shares   -    12,399 
Options   31,654    27,143 

 

NOTE 5 – SEGMENT INFORMATION

 

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company reports and evaluates financial information for three current segments: Security segment, Industrial Services segment and the Corporate segment.

 

The following tables summarize the Company’s segment information:

   Security  

Industrial

Services

   Corporate 
   Three months ended December 31, 2022 
   Security  

Industrial

Services

   Corporate 
Revenues  $7,004,744   $4,965,498   $- 
Cost of revenues   3,601,054    3,326,573    - 
Gross profit  $3,403,690   $1,638,925   $- 
Operating expenses               
Sales, general, and administrative   2,749,429    1,188,865    986,709 
Depreciation and amortization   331,155    167,521    32,154 
Research and development   1,538,218    -    - 
Operating loss  $(1,215,112)  $282,539   $(1,018,863)
                
Other income/(expense)  $(112,399)  $(31,560)  $(1,001,358)

 

   Security  

Industrial

Services

   Corporate 
   Three months ended December 31, 2021 
   Security   Industrial Services   Corporate 
Revenues  $4,359,423    5,053,972   $- 
Cost of revenues   2,567,358    3,623,787    - 
Gross profit  $1,792,065   $1,430,185   $- 
Operating expenses               
Sales, general, and administrative   2,859,964    1,410,861    929,423 
Depreciation and amortization   31,778    179,223    36,702 
Research and development   1,072,898    -    - 
Operating loss  $(2,172,575)  $(159,899)  $(966,125)
                
Other income/(expense)  $861,700   $(51,048)  $(1,282,918)

 

16
 

 

   December 31,   September 30, 
   2022   2022 
Identifiable Assets          
Security  $17,722,829   $12,052,177 
Industrial Services   17,382,118    16,658,984 
Corporate   5,802,342    13,077,101 
Discontinued operations   2,327    3,969,366 
Total Assets  $40,909,616   $45,757,628 

 

NOTE 6 – RESTRICTED CASH

 

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. These funds, as required by the plan are restricted in nature and amounted to $1,601,723 at December 31, 2022 and $1,577,915 at September 30, 2022.

 

NOTE 7 – FAIR VALUE MEASUREMENTS

 

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

 

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities investments and investment funds. We measure trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

 

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

 

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability to continue as a going concern.

 

17
 

 

The Company’s fair value assets at December 31, 2022 and September 30, 2022, are as follows.

 

   Quoted Prices   Significant   -   - 
   in Active   Other   Significant   Balance 
   Markets for   Observable   Unobservable   as of 
   Identical Assets   Inputs   Inputs   December 31, 
   (Level 1)   (Level 2)   (Level 3)   2022 
Assets                                          
Investment in marketable securities                    
(included in short-term investments)  $13,721   $-   $-   $13,721 
                     
Fair value assets  $13,721   $-   $-   $13,721 

 

   Quoted Prices   Significant   -   - 
   in Active   Other   Significant   Balance 
   Markets for   Observable   Unobservable   as of 
   Identical Assets   Inputs   Inputs   September 30, 
   (Level 1)   (Level 2)   (Level 3)   2022 
Assets                                         
Investment in marketable securities                    
(included in short-term investments)  $13,721   $-   $-   $13,721 
                     
Fair value assets  $13,721   $-   $-   $13,721 

 

NOTE 8 – TRADE RECEIVABLES, NET

 

Trade receivables, net consist of the following:

   December 31,   September 30, 
   2022   2022 
Trade receivables  $7,190,026   $5,648,655 
Allowance for doubtful accounts   (253,949)   (249,439)
Accounts receivables, net, total  $6,936,077   $5,399,216 

 

Trade receivables include amounts due for shipped products and services rendered.

 

Allowance for doubtful accounts includes estimated losses resulting from the inability of our customers to make the required payments.

 

NOTE 9 – INVENTORY, NET

 

Inventory, net, consist of the following:

 

   December 31,   September 30, 
   2022   2022 
Raw materials  $1,420,041   $1,375,933 
Work in progress   105,076    120,026 
Finished goods   8,178,978    8,080,235 
Inventory, gross   9,704,095    9,576,194 
Less: Allowance for inventory obsolescence   (1,099,336)   (1,088,377)
Inventory –net of allowance for inventory obsolescence  $8,604,759   $8,487,817 

 

18
 

 

NOTE  10 – PREPAID AND OTHER CURRENT ASSETS

 

On December 31, 2022, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $1,445,861, costs and estimated earnings in excess of billings on uncompleted contracts of $521,172, and other current assets of $1,125,585. On September 30, 2022, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $414,997, costs and estimated earnings in excess of billings on uncompleted contracts of $781,819, accrued income taxes refunds on foreign operations of $37,761, and prepaid expenses and other current assets of $1,187,067.

 

NOTE 11 – PROPERTY AND EQUIPMENT

 

Property and equipment are summarized as follows:

 

   December 31,   September 30, 
   2022   2022 
Land  $790,373   $790,373 
Building and leasehold improvements   2,913,851    2,906,953 
Furniture and office equipment   552,931    546,548 
Computers and software   376,996    365,892 
Machinery and equipment   11,270,672    11,242,709 
Property and equipment, gross   15,904,823    15,852,475 
Less: Accumulated depreciation   (10,796,556)   (10,572,033)
Property and equipment, net  $5,108,267   $5,280,442 

 

Depreciation expense for the three months ended December 31, 2022, and 2021 were $530,830, and $262,833, respectively.

 

NOTE 12 – OTHER ASSETS 

 

As of December 31, 2022, the Company had other assets of $1,546,101which was comprised of rent security of $62,041, a strategic investment in MasterpieceVR of $1,000,000 (see below), and other assets of $484,060. As of September 30, 2022, the Company had other assets of $1,399,745 which was comprised of rent security deposits of $204,388, Investment in Masterpiece VR valued at $1,000,000, and other assets of $195,357.

 

On November 13, 2020, Cemtrex made a $500,000 investment and on January 19, 2022, made an additional $500,000 investment via a simple agreement for future equity (“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying balance sheet and the Company accounts for this investment and recorded at cost. No impairment has been recorded for the quarter ended December 31, 2022.

 

NOTE 13 – RELATED PARTY TRANSACTIONS

 

On August 31, 2019, the Company entered into an Asset Purchase Agreement for the sale of Griffin Filters, LLC to Ducon Technologies, Inc., which Aron Govil, the Company’s Founder and former CFO, for total consideration of $550,000. On July 31, 2022, the Company negotiated a payment agreement surrounding the sale of Griffin Filters, LLC and other liabilities due to Cemtrex, Inc. totaling $761,585. This agreement is in the form of a secured promissory note earning interest at a rate of 5% per annum and matures on July 31, 2024.

 

As of December 31, 2022, and September 30, 2022, there was $19,034 and $19,133 payable due to Ducon Technologies, Inc., respectively.

 

Receivables of $708,512 that represented the amount due from Ducon to Cemtrex Technologies Pvt. Ltd. the Company’s subsidiary based in India were written off to bad debt in fiscal year 2022.

 

19
 

 

On February 26, 2021, the Company entered into a Settlement Agreement and Release with Aron Govil regarding transactions Cemtrex’s Board of Directors determined were incorrectly handled and accounted for. Mr. Govil executed a secured promissory note (the “Note”) in the amount of $1,533,280. The Note matures and is due in full in two years and bears interest at 9% per annum and is secured by all of Mr. Govil’s assets. Mr. Govil also agreed to sign an affidavit confessing judgment in the event of a default on the Note. While the Company believes the note is fully collectible, in accordance with ASC 450-30, Gain Contingencies, the Company determined the gain will not be recognized until the note is paid. Accordingly, the note and associated gain is not presented on the Company’s Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations.

 

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc., which include the brands SmartDesk, Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil (see NOTE 1).

 

As of December 31, 2022, there was $383,710 in trade receivables due from these companies. $107,910 of these receivables are related to costs paid by Cemtrex related to payroll during the transition of employees to the new company. The remaining $275,800 are related to services provided by Cemtrex Technologies Pvt. Ltd. in the normal course of business.

 

As of December 31, 2022, there were royalties receivable from the sale of Cemtrex, XR, Inc. of $665,048.

 

NOTE 14 – LEASES

 

The Company is party to contracts where we lease property from others under contracts classified as operating leases. The Company primarily leases office and operating facilities, vehicles, and office equipment. The weighted average remaining term of our operating leases was approximately 3.6 years at December 31, 2022 and 4.3 years at December 31, 2021. Lease liabilities were $2,520,506 with $787,561classified as short-term at December 31, 2022, and $2,576,963 with $754,495, classified as short-term at September 30, 2022. The weighted average discount rate used to measure lease liabilities was approximately 5.6% at December 31, 2022 and 6.6% at December 31, 2021. The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

 

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 

A reconciliation of undiscounted cash flows to operating lease liabilities recognized in the condensed consolidated balance sheet at December 31, 2022, is set forth below:

 

Years ending September 30,  Operating Leases 
2023   667,747 
2024   755,686 
2025   733,327 
2026   539,279 
2027 & Thereafter   205,358 
Undiscounted lease payments   2,901,397 
Amount representing interest   (380,891)
Discounted lease payments  $2,520,506 

 

Lease costs for the three months ended December 31, 2022 and 2021 are set forth below.:

 

   2022   2021 
   For the three months ended 
   December 31, 
   2022   2021 
Lease costs:          
Finance lease costs  $-   $17,272 
Operating lease costs   261,433    980,062 
Total lease cost  $261,433   $997,334 

 

20
 

 

NOTE 15 – LINES OF CREDIT AND LONG-TERM LIABILITIES

 

The following table outlines the Company’s lines of credit and liabilities.

 

         December 31,   September 30, 
   Interest Rate  Maturity  2022   2022 
Fulton Bank line of credit $3,500,000 - The terms of this line of credit are subject to the bank’s review annually on February 1.  Secured Overnight Financing Rate (“SOFR”) plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022)  N/A  $-   $- 
                 
Fulton Bank loan $5,250,000 for the purchase of AIS $5,000,000 of the proceeds went to the direct purchase of AIS. This loan is secured by certain assets of the Company.  SOFR plus 2.37%(6.67% as of December 31, 2022 and 5.35% as of September 30, 2022)  12/15/2022   -    247,284 
                 
Fulton Bank loan $400,000 fund equipment for AIS. The Company was in compliance with loan covenants as of December 31, 2022. This loan is secured by certain assets of the Company.  SOFR plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022)  5/1/2023   39,843    63,280 
                 
Fulton Bank - $360,000 fund equipment for AIS. The Company was in compliance with loan covenants as of December 31, 2022. This loan is secured by certain assets of the Company.  SOFR plus 2.37% (6.67% as of December 31, 2022 and 5.35% as of September 30, 2022).  5/1/2023   165,518    183,839 
                 
Fulton Bank mortgage $2,476,000. The Company was in compliance with loan covenants as of December 31, 2022.  SOFR plus 2.62% (6.92% as of December 31, 2022 and 5.6% as of September 30, 2022).  1/28/2040   2,228,157    2,245,664 
                 
Note payable - $439,774. For the purchase of VDI. Payable in two installments on October 26, 2021, and October 26, 2022.  5%  10/26/2022   -    219,370 
                 
Note payable - $5,755,000 - Less original issue discount $750,000 and legal fees $5,000, net cash received $5,000,000 Unamortized original issue discount balance of $125,000 and $250,000, as of December 31, 2022 and September 30, 2022respectively.  8%  3/30/2023   4,921,279    4,943,929 
                 
Note payable - $9,205,000. Less original issue discount $1,200,000 and legal fees $5,000,net cash received $8,000,000. 28,572 shares of common stock valued at $700,400 recognized as additional original issue discount. Unamortized original issue discount balance of $739,044 and$1,064,778 as of December 31, 2022 and September 30, 2022 respectivly.  8%  8/23/2023   10,089,381    9,738,632 
                 
Term Loan Agreement with NIL Funding Corporation (“NIL”) - $5,600,000 The Company was in compliance with loan covenants as of December 31, 2022.  8.85%  3/30/2023   2,729,743    2,804,743 
                 
Paycheck Protection Program loan - $121,400 - The issuing bank determined that this loan qualifies for loan forgiveness; however the Company is awaiting final approval from the Small Business Administration.     5/5/2025   121,400    121,400 
Total Notes Payable        $20,295,321   $20,568,141 
Less: Current maturities         (17,099,485)   (16,894,743)
Notes Payable, Long Term        $3,195,836   $3,673,398 

 

21
 

 

NOTE 16 – SHAREHOLDERS’ EQUITY

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of Preferred Stock, $0.001 par value. As of December 31, 2022, and September 30, 2022, there were 2,233,463 and 2,129,122 shares issued and 2,169,363 and 2,065,022 shares outstanding, respectively.

 

Series 1 Preferred Stock

 

During the three months ended December 31, 2022, 104,341 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

 

As of December 31, 2022, and September 30, 2022, there were 2,183,463 and 2,079,122 shares of Series 1 Preferred Stock issued and 2,119,363 and 2,015,022 shares of Series 1 Preferred Stock outstanding, respectively.

 

Series C Preferred Stock

 

As of December 31, 2022, and September 30, 2022, there were 50,000 shares of Series C Preferred Stock issued and outstanding.

 

Common Stock

 

On January 25, 2023, the Company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

 

The Company is authorized to issue 50,000,000 shares of common stock, $0.001 par value. As of December 31, 2022, there were 793,727 shares issued and outstanding and at September 30, 2022, there were 754,711 shares issued and outstanding.

 

During the three months ended December 31, 2022, 39,016 shares of the Company’s common stock have been issued to satisfy $31,331 of notes payable, $168,669 in accrued interest, and $32,145 of excess value of shares issued recorded as interest expense.

 

NOTE 17 – SHARE-BASED COMPENSATION

 

For the three months ended December 31, 2022, and 2021, the Company recognized $39,842 and $45,371 of share-based compensation expense on its outstanding options, respectively. As of December 31, 2022, $152,433 of unrecognized share-based compensation expense is expected to be recognized over a period of four years. Future compensation amounts will be adjusted for any change in estimated forfeitures.

 

During the three months ended December 31, 2022, options to purchase 2,931 shares of the Company’s common stock at an exercise price of $13.65 per share were cancelled.

 

NOTE 18 – COMMITMENTS AND CONTINGENCIES

 

The Company has its corporate headquarters in New York City with a 12-month lease of 2,500 square feet of office space at a rate of $10,000 per month expiring on February 28, 2023.

 

The Company’s Industrial Services segment owns approximately 25,000 square feet of warehouse space in Manchester, PA and approximately 43,000 square feet of office and warehouse space in York, PA. The IS segment also leases approximately 15,500 square feet of warehouse space in Emigsville, PA from a third party in a three-year lease at a monthly rent of $4,555 expiring on August 31, 2025.

 

22
 

 

The Company’s Security segment leases (i) approximately 6,700 square feet of office and warehouse space in Pune, India from a third party in an five year lease at a monthly rent of $6,453 (INR456,972) expiring on February 28, 2024, (ii) approximately 30,000 square feet of office and warehouse space in Hauppauge, New York from a third party in a seven-year lease at a monthly rent of $28,719 expiring on March 31, 2027, and (iii) approximately 9,400 square feet of office and warehouse space in Hampshire, England in a fifteen-year lease with at a monthly rent of $7,3295,771) which expires on March 24, 2031 and contains provisions to terminate in 2026.

 

NOTE 19 – SUBSEQUENT EVENTS

 

Reverse Stock Split

 

On January 25, 2023, the company completed a 35:1 reverse stock split on its common stock. All share and per share data have been retroactively adjusted for this reverse split.

 

Extension of cure period

 

On January 26, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that, it had been granted an additional 180 days or until July 24, 2023, to regain compliance with the Minimum Bid Price Requirement on its Series 1 Preferred stock.

 

Listing Rule Compliance

 

On February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company’s common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has been cancelled.

 

23
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company’s ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

 

General Overview

 

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. The currently operates in two areas: industrial services, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

During the first quarter of fiscal year 2023, The Company reorganized its reporting segments to be in line with its current structure. The Company has three business segments, consisting of (i) Security (ii) Industrial Services and (iii) Cemtrex Corporate.

 

Security

 

Cemtrex’s Security segment operates under the Vicon Industries brand. Vicon Industries, a majority owned subsidiary, provides end-to-end security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals among others. We are a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

 

Cemtrex Corporate

 

Cemtrex’s Corporate segment is the holding company of our other two segments.

 

24
 

 

Significant Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

 

Certain of our accounting policies are deemed “significant”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended September 30, 2022.

 

Results of Operations – For the three months ending December 31, 2022, and 2021

 

Total revenue for the three months ended December 31, 2022, and 2021 was $11,970,242 and $9,413,395, respectively, an increase of $2,556,847, or 27%. Loss from continuing operations for the three months ended December 31, 2022, was $3,096,753 compared to $3,770,865 for the three months ended December 31, 2021, a decrease on the loss of $674,112, or 18%. Total revenue for the quarter increased, as compared to total revenue in the same period last year, due to increased demand for the Company’s products and services. Loss from operations decreased due to increased revenues as compared to the same period in the prior year.

 

Revenues

 

Our Security segment revenues for the three months ended December 31, 2022, increased by $2,646,131 or 40% to $7,004,744 from $4,358,613 for the three months ended December 31, 2021. This increase is due to an increased demand for Security technology.

 

Our Industrial Services segment revenues for the three months ended December 31, 2022, decreased by $88,474 or 2%, to $4,965,498 from $5,053,972 for the three months ended December 31, 2021. This decrease is mainly due to timing of the recognition of revenue for the segment’s products and services.

 

Gross Profit

 

Gross Profit for the three months ended December 31, 2022, was $5,042,615 or 42% of revenues as compared to gross profit of $3,222,250 or 34% of revenues for the three months ended December 31, 2021.

 

Gross profit in our Security segment was $3,403,690 or 49% of the segment’s revenues for the three months ended December 31, 2022 as compared to gross profit of $1,791,255 or 41% of the segment’s revenues for the period ended December 31, 2021. Gross profit as a percentage of revenues increased in the three months ended December 31, 2022, compared to the three months ended December 31, 2021, due to price increases implemented throughout the segment in response to rising costs of our goods and transportation costs.

 

Gross profit in our Industrial Services segment was $1,638,925 or 33% of the segment’s revenues for the three months ended December 31, 2022 as compared to gross profit of $1,430,185 or 28% of the segment’s revenues for the period ended December 31, 2021. Gross profit as a percentage of revenues increased in the three months ended December 31, 2022, compared to the three months ended December 31, 2021, was primarily due to lower subcontractor costs.

 

25
 

 

General and Administrative Expenses

 

General and administrative expenses for the three months ended December 31, 2022, increased $7,882 or 0.14% to $5,455,833 from $5,447,951 for the three months ended December 31, 2021. General and administrative expenses as a percentage of revenues were 46% and 58% of revenues for the three-month periods ended December 31, 2022, and 2021, respectively.

 

Research and Development Expenses

 

Research and Development expenses for the three months ended December 31, 2022, were $1,538,218 compared to $1,072,898 for the three months ended December 31, 2021. Research and Development expenses are primarily related to the Security Segment’s development of next generation solutions associated with security and surveillance systems software.

 

Other Income/(Expense)

 

Other income/(expense) for the first quarter of fiscal 2022, was an expense of $1,145,317 as compared to an expense of $472,266 for the first quarter of fiscal 2021. Other income/(expense) for the three months ended December 31, 2022, was mainly driven by interest on the Company’s debt. Other income/(expense) for the three months ended December 31, 2021, included the gain on the forgiveness of our PPP loans of $971,500.

 

Provision for Income Taxes

 

During the first quarters of fiscal 2022, and 2021, the Company took no provision on income taxes. The provision for income tax is based upon the projected income tax from the Company’s various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company’s projected ability to utilize net loss carryforwards.

 

Loss from Discontinued Operations

 

As discussed in Note 3, the Company had losses on discontinued operations of $3,239,621. The losses are comprised of the $2,455,701 loss on the sale of Cemtrex Advanced Technologies, and Cemtrex XR, Inc.. The net loss of $877,792 for the three months ended December 31, 2022, and the net gain on the recovery of cash from Vicon Industries Ltd. of $89,085. Losses on discontinued operations for the three months ended December 31, 2021 were $758,241 attributable to the operations of the Cemtrex brands discussed in Note 3.

 

Net income/(loss) attributable to Cemtrex, Inc. shareholders

 

The Company had a net loss attributable to Cemtrex, Inc. shareholders of $6,277,711, or 52% of revenues, for the three-month period ended December 31, 2022, as compared to net loss attributable to Cemtrex, Inc. shareholders of $4,477,951 or 42% of revenues, for the three months ended December 31, 2021. The net loss attributable to Cemtrex, Inc. shareholders increased in the first quarter as compared to the same period last year was primarily due to the loss on discontinued operations.

 

Effects of Inflation

 

The Company’s business and operations have not been materially affected by inflation during the periods for which financial information is presented.

 

Liquidity and Capital Resources

 

Working capital deficit was $469,270 at December 31, 2022, compared to working capital of $4,754,493 at September 30, 2022. This includes cash and equivalents and restricted cash of $7,370,333 at December 31, 2022, and $12,188,096 at September 30, 2022. The decrease in working capital was primarily due to the Company’s transfer of cash to in the sale of Cemtrex Advanced Technologies and Cemtrex XR, Inc. and accrual of interest on short-term liabilities during the first quarter of fiscal year 2023.

 

26
 

 

Cash used by operating activities for continuing operations for the three months ended December 31, 2022 and 2021 was $5,872,310 and $3,633,702 respectively. Cash provided by operating activities for discontinued operations for the three months ended December 31, 2022 was $2,501,426, compared to using cash of $719,237. The increase in operating cash usage for continuing operations was primarily due to increases of trade receivables, prepaid expenses, and other assets and payment of accounts payable and other liabilities.

 

Trade receivables increased $1,536,861 or 28% to $6,936,077 at December 31, 2022, from $5,399,216 at September 30, 2022. The increase in trade receivables is attributable to increased sales in the Security segment.

 

Inventories increased $116,492 or 1% to $8,604,759 at December 31, 2022, from $8,487,817 at September 30, 2022. The increase in inventories is attributable to inventories in transit yet to be sold.

 

Cash used by investment activities for continuing operations for the three months ended December 31, 2022 was $568,111 compared to $291,666 for the three-month period ending December 31, 2021. Cash provided by investing activities for discontinued operations for the three months ended December 31, 2022 was $207,329. Investing activities for the first quarter of fiscal year 2023 were driven mainly by the Company’s purchase of property and equipment.

 

Cash used by financing activities for the three months ended December 31, 2022, was $600,920 compared to $632,753 for the three-month period ending December 31, 2021. Financing activities were primarily driven by payments on the Company’s debt and the royalties receivable for discontinued operations.

 

While our working capital deficit and current debt indicate a substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. Additionally, the Company has recently sold unprofitable brands, reducing the cash required to maintain those brands, reevaluated our pricing model on our Vicon brand to improve margins on those products, and has effected a reverse stock split on our common stock to remain trading on the Nasdaq Capital Markets, and improved our ability to potentially raise capital through equity offerings that we may use to satisfy debt. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans are sufficient to meet the capital demands of our current operations for at least the next twelve months, the is no guarantee that we will succeed.

 

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. We currently do not have adequate cash to meet our short or long-term needs. The consolidated financial statements do not include any adjustments relating to this uncertainty.

 

27
 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022. Based on their evaluation, our management has concluded that as of December 31, 2022, our disclosure controls and procedures were not effective and there is a material weakness in our internal control over financial reporting. The material weakness relates to the Company lacking sufficient accounting personnel. The shortage of accounting personnel resulted in the Company lacking entity level controls around the review of period-end reporting processes, accounting policies and public disclosures. Additionally, the Company’s current processes and systems do not provide for necessary, timely reconciliation of certain accounts and sufficient consideration regarding recoverability of certain assets. This deficiency is common in small companies, similar to us, with limited personnel.

 

Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of December 31, 2022, were not effective, and notwithstanding the material weakness in our internal control over financial reporting described below, management believes that the unaudited condensed financial statements and related financial information included in this Quarterly Report fairly present in all material respects our financial condition, results of operations and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with GAAP.

 

In order to mitigate the material weaknesses, the Company has implemented measures that they believe have mitigated these weaknesses but has not had sufficient time to fully evaluate these measures. These measures include; (i) updating our accounting software to ensure tighter control over entries and providing improved data for timely reconciliation of certain accounts, and (ii) engaged a third-party accounting firm to provide review of period-end reporting processes, accounting policies and public disclosures.

 

Changes in Internal Control Over Financial Reporting

 

While there was no change in the Company’s internal control over financial reporting during the Company’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting, the Company is continuing to improve its internal controls through the actions mentioned above.

 

Limitations on the Effectiveness of Controls

 

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

28
 

 

Part II Other Information

 

Item 1. Legal Proceedings.

 

NONE.

 

Item 1A. Risk Factors

 

See Risk Factors included in our Annual Report on Form 10-K for 2022.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended December 31, 2022, 39,016 shares of the Company’s common stock have been issued to satisfy $31,331 of notes payable, $168,669 in accrued interest, and $32,145 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

29
 

 

Item 6. Exhibits

 

Exhibit No.   Description
2.2   Stock Purchase Agreement regarding the stock of Advanced Industrial Services, Inc., AIS Leasing Company, AIS Graphic Services, Inc., and AIS Energy Services, LLC, Dated December 15, 2015. (8)
3.1   Certificate of Incorporation of the Company.(1)
3.2   By Laws of the Company.(1)
3.3   Certificate of Amendment of Certificate of Incorporation, dated September 29, 2006.(1)
3.4   Certificate of Amendment of Certificate of Incorporation, dated March 30, 2007.(1)
3.5   Certificate of Amendment of Certificate of Incorporation, dated May 16, 2007.(1)
3.6   Certificate of Amendment of Certificate of Incorporation, dated August 21, 2007.(1)
3.7   Certificate of Amendment of Certificate of Incorporation, dated April 3, 2015.(3)
3.8   Certificate of Designation of the Series A Preferred Shares, dated September 8, 2009.(2)
3.9   Certificate of Designation of the Series 1 Preferred Stock.(11)
3.10   Certificate of Amendment of Certificate of Incorporation, dated September 7, 2017 (12)
3.11   Certificate of Correction to the Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Cemtrex, Inc (6)
3.12   Amended Certificate of Designation of the Series 1 Preferred Shares, dated March 30, 2020.(16)
3.13   Certificate of Amendment of Certificate of Incorporation, dated July 29, 2020 (20)
3.14   Certificate of Correction of Certificate of Incorporation, dated July 29, 2021, filed October 7, 2020 (9)
    Certificate of Amendment of Certificate of Incorporation, dated January 12, 2023 (7)
4.1   Form of Subscription Rights Certificate. (10)
4.2   Form of Series 1 Preferred Stock Certificate. (10)
4.3   Form of Series 1 Warrant. (10)
4.4   Form of Common Stock Purchase Warrant, dated March 22, 2019. (14)
10.1   Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 4, 2020.(17)
10.2   Consulting Agreement, dated April 22, 2020 between Centrex, Inc. and Adtron, Inc. (5)
10.3   Securities Purchase Agreement dated June 1, 2020 (18)
10.4   Securities Purchase Agreement dated June 9, 2020 (19)
10.5   Settlement Agreement and Release between Cemtrex, Inc. and Aron Govil dated February 26, 2021 (13)
10.6   Securities Purchase Agreement dated February 22, 2022 (15)
10.7   Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 30, 2022. (15)
10.8   Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022 (22)
10.9   Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022 (22)
10.10   Simple Agreement for Future Equity (SAFE) between Cemtrex, Inc. and Saagar Govil, dated November 18, 2022 (22)
14.1   Corporate Code of Business Ethics.(4)
21.1*   Subsidiaries of the Registrant
31.1*   Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Interim Chief Financial Officer and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
32.2*   Certification of Interim Chief Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
99.1   Order pursuant to Section 8A of the Securities Act – dated September 30, 2022. (21)
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith
1 Incorporated by reference from Form 10-12G filed on May 22, 2008.
2 Incorporated by reference from Form 8-K filed on September 10, 2009.
3 Incorporated by reference from Form 8-K filed on August 22, 2016.
4 Incorporated by reference from Form 8-K filed on July 1, 2016.
5 Incorporated by reference from Form S-8 filed on May 1, 20120
6 Incorporated by reference from Form 8-K filed on June 12, 2019.
7 Incorporated by reference from Form 8-K filed on January 20, 2023.
8 Incorporated by reference from Form 8-K/A filed on September 26, 2016.
9 Incorporated by reference from Form 10-Q filed on May 28, 2021.
10 Incorporated by reference from Form S-1 filed on August 29, 2016 and as amended on November 4, 2016, November 23, 2016, and December 7, 2016.
11 Incorporated by reference from Form 8-K filed on January 24, 2017.
12 Incorporated by reference from Form 8-K filed on September 8, 2017.
13 Incorporated by reference from Form 8-K filed on February 26, 2021.
14 Incorporated by reference from Form 8-K filed on March 22, 2019.
15 Incorporated by reference from Form 10-Q filed on May 16, 2022.
16 Incorporated by reference from Form 8-K filed on April 1, 2020.
17 Incorporated by reference from Form 8-K filed on March 9, 2020.
18 Incorporated by reference from Form 8-K filed on June 4, 2020.
19 Incorporated by reference from Form 8-K filed on June 12, 2020.
20 Incorporated by reference from Form 10-K filed on January 5, 2021.
21 Incorporated by reference from Form 8-K filed on October 4, 2022.
22 Incorporated by reference from Form 8-K filed on November 29, 2022.

 

30
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Cemtrex, Inc.
       
Dated: February 14, 2023 By: /s/ Saagar Govil
      Saagar Govil
      Chief Executive Officer
       
Dated: February 14, 2023   /s/ Paul J. Wyckoff
      Paul J. Wyckoff
      Interim Chief Financial Officer
      and Principal Financial Officer

 

31